Event Description
23 - 24 October 2024
Orléans, France
Onsite
This course provides a deep dive into antimicrobial stewardship, focusing on pharmacokinetics, dynamics, and technological tools. Participants gain insights into optimizing antibiotic therapy, understanding drug distribution, dosing schedules, and dose adjustments tailored to patient conditions. Topics include allergy management, therapeutic drug monitoring, and leveraging IT resources for surveillance and decision support. Participants emerge equipped to lead AMS initiatives and harness technology for improved antimicrobial use.
Intended audience:
Medical and pharmaceutical doctors, with an interest in infectious diseases and antimicrobial stewardship.
Objectives:
- Pharmacokinetics: knows and understands the pharmacokinetics of antibiotics related to AMS
- Extracellular/intracellular distribution of antimicrobials and its implication for antibiotic prescribing
- Pharmacodynamics: knows the mechanism of action of antimicrobials, their clinically relevant antimicrobial spectra, and understands the pharmacodynamics properties important for antimicrobial dosing
- Allergy: knows and understands the pathogenesis of allergy to antimicrobials and its clinical presentation, and can plan the therapy to avoid the risk of allergy, knows the principles of de-labelling and as a leader be capable of organizing de-labelling in their setting
- Availability of antimicrobials: knows the antimicrobials listed in the formulary in his setting and their trade names, contributes to proper inclusion of new antimicrobial drugs in the formulary, knows the risks of drug shortages and is capable to respond to the shortages according to the setting
- The dose / dosing interval (incl. prolonged and continuous infusion): understands the benefits and risks of dosing schedules, can plan appropriate dosing schedules, and is able to explain them to the primary team and the patient
- Dosing in renal failure, during various renal replacement therapies and during extracorporeal membrane oxygenation, in nebulizators
- Knows how to adjust the dose of antimicrobials according to the changes in pharmacokinetic of antibiotics related to the patient condition (decreased renal and hepatic function, severe burns, oedema, etc.)
- Therapeutic drug monitoring (TDM): understands the need for TDM, knows how the interpret the results, and as a leader is capable of organizing TDM in the setting
- Knows and understands the statistical methods for the analysis of AMS interventions
- Knows the IT resources available outside the workplace that may be useful for AMS and knows how to use them
- Knows how to use IT support available in the setting to monitor and improve antimicrobial use
- Knows and understands the use of information technology in surveillance, medication management, and AMS interventions (education, restrictions, drug approval)
- Knows and understands the use of electronic clinical decision support, telehealth, and smartphone apps in antibiotic prescribing and AMS
- Understands the benefits of computerized medical records including computerized prescribing of antimicrobials and contributes to the development and use of the programs
Course coordinators:
Guillaume Beraud
Organisers:
ESCMID
University Hospital of Orléans
Accreditation:
This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9.5 European CME credits (ECMEC®s).
Certification:
Course organisers will monitor attendance. Only participants attending live sessions will be able to receive the certification.
Course Venue:
University Hospital of Orleans
Amphithéatre Jacques Guillemeau
14, avenue de l'hôpital 45100 Orléans France
Accommodation:
Accommodation is not included in the fee.
Registration details:
This course is part of the AMS Certificate Programme, but has some spaces open to registrations outside of the programme.
Registration fees includes full access to the course, coffee breaks and lunches. Travel costs and accommodation are not included in the fee.